生物活性 | |||
---|---|---|---|
描述 | The cation channel transient receptor potential canonical (TRPC) 6 has been associated with several pathologies including focal segmental glomerulosclerosis, pulmonary hypertension and ischaemia reperfusion-induced lung oedema. SAR7334 inhibited TRPC6, TRPC3 and TRPC7-mediated Ca2+ influx into cells with IC50s of 9.5, 282 and 226 nM. SAR7334 dose-dependently reduces TRPC6 currents with an IC50 of 7.9 nM. In most TRPC6-HEK-FITR cells, trypsin evoked large, rapidly declining TRPC6 currents that reached an almost steady-state level within 30–60 s. This current was substantially reduced by 100 nM SAR7334. The reduction of trypsin-induced TRPC6 currents by 100 nM SAR7334 amounted to 88 ± 3% (n = 5). In perfused isolated lungs from mice, SAR7334 abolished hypoxia-induced increases in pulmonary arterial pressure. Half maximal inhibition was achieved at about 100 nM indicating that SAR7334 is able to efficiently block native TRPC6 channels in situ[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.59mL 2.72mL 1.36mL |
27.18mL 5.44mL 2.72mL |
参考文献 |
---|